Kinesin 18A expression: Clinical relevance to colorectal cancer progression

International Journal of Cancer

Volumn 129, Issue 11, 2011, Pages 2543-2552

  Nagahara, Makoto ^a,b   Nishida, Naohiro ^a,c   Iwatsuki, Masaaki ^a   Ishimaru, Shinya ^a,b   Mimori, Koshi ^a   Tanaka, Fumiaki ^a   Nakagawa, Tsuyoshi ^b   Sato, Takanobu ^b   Sugihara, Kenichi ^b   Hoon, Dave S B ^c   Mori, Masaki ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

colorectal cancer; Kinesin 18A; metastasis

Indexed keywords

KINESIN; KINESIN 18A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE FREE SURVIVAL; TRANSLATIONAL RESEARCH; TUMOR GROWTH; UPREGULATION;

BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KINESIN; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 80053308276     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25916     Document Type: Article

References (50)

1. World Health Organization, Cancer. Web-based Report, 2009.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
3. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
4. Cunningham D, Findlay M,. The chemotherapy of colon cancer can no longer be ignored. Eur J Cancer 1993; 29A: 2077-9. (Pubitemid 23348118)
5. Van Cutsem E, Nordlinger B, Adam R, Kohne CH, Pozzo C, Poston G, Ychou M, Rougier P,. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006; 42: 2212-21. (Pubitemid 44307626)
6. Yoo PS, Lopez-Soler RI, Longo WE, Cha CH,. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer 2006; 6: 202-7. (Pubitemid 44596769)
7. Malumbres M, Barbacid M,. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-66.
8. Eswaran J, Soundararajan M, Knapp S,. Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev 2009; 28: 209-17.
9. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology v.2. 2011.
10. Huszar D, Theoclitou ME, Skolnik J, Herbst R,. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 2009; 28: 197-208.
11. Marcus AI, Peters U, Thomas SL, Garrett S, Zelnak A, Kapoor TM, Giannakakou P,. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells. J Biol Chem 2005; 280: 11569-77. (Pubitemid 40418469)
12. Vale RD, Fletterick RJ,. The design plan of kinesin motors. Annu Rev Cell Dev Biol 1997; 13: 745-77. (Pubitemid 28034538)
13. Sharp DJ, Rogers GC, Scholey JM,. Microtubule motors in mitosis. Nature 2000; 407: 41-7.
14. Kline-Smith SL, Walczak CE,. Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol Cell 2004; 15: 317-27. (Pubitemid 39092749)
15. Miki H, Setou M, Kaneshiro K, Hirokawa N,. All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci USA 2001; 98: 7004-11. (Pubitemid 32567894)
16. Kamal A, Goldstein LS,. Principles of cargo attachment to cytoplasmic motor proteins. Curr Opin Cell Biol 2002; 14: 63-8. (Pubitemid 34131658)
17. Karcher RL, Deacon SW, Gelfand VI,. Motor-cargo interactions: the key to transport specificity. Trends Cell Biol 2002; 12: 21-7. (Pubitemid 34164153)
18. Vale RD,. The molecular motor toolbox for intracellular transport. Cell 2003; 112: 467-80. (Pubitemid 36263080)
19. Mayr MI, Hummer S, Bormann J, Gruner T, Adio S, Woehlke G, Mayer TU,. The human kinesin Kif18A is a motile microtubule depolymerase essential for chromosome congression. Curr Biol 2007; 17: 488-98. (Pubitemid 46401386)
20. Stumpff J, von Dassow G, Wagenbach M, Asbury C, Wordeman L,. The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment. Dev Cell 2008; 14: 252-62. (Pubitemid 351189173)
21. Gardner MK, Odde DJ, Bloom K,. Kinesin-8 molecular motors: putting the brakes on chromosome oscillations. Trends Cell Biol 2008; 18: 307-10.
22. Cleveland DW, Mao Y, Sullivan KF,. Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 2003; 112: 407-21. (Pubitemid 36263076)
23. Hartwell LH, Kastan MB,. Cell cycle control and cancer. Science 1994; 266: 1821-8.
24. Zhang C, Zhu C, Chen H, Li L, Guo L, Jiang W, Lu SH,. Kif18A is involved in human breast carcinogenesis. Carcinogenesis 2010; 31: 1676-84.
25. Japanese Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer, rectum and anus. Tokyo: Kanehara, 2006.
26. Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD Jr, Chen LB,. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 1993; 8: 2821-6. (Pubitemid 23279111)
27. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, Akiyoshi T,. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology 1995; 109: 1522-5.
28. Ogawa K, Utsunomiya T, Mimori K, Tanaka Y, Tanaka F, Inoue H, Murayama S, Mori M,. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br J Cancer 2004; 91: 282-6. (Pubitemid 39037073)
29. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R, Curmi PA,. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 1998; 78: 701-9. (Pubitemid 28418300)
30. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M,. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998; 78: 661-6. (Pubitemid 28507194)
31. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M,. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999; 45: 1148-56. (Pubitemid 29424251)
32. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M,. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 2008; 15: 2927-33.
33. Adrain C, Slee EA, Harte MT, Martin SJ,. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J Biol Chem 1999; 274: 20855-60.
34. Davies J, Jimenez A,. A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg 1980; 29: 1089-92. (Pubitemid 11240793)
35. Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, Inoue H, Kuwano H, Mori M,. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer 2007; 121: 33-8. (Pubitemid 46753848)
36. Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S,. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst 2006; 98: 491-8.
37. Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M,. MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene 2003; 22: 3463-71. (Pubitemid 36713744)
38. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
39. Mantel N,. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
40. Miki H, Okada Y, Hirokawa N,. Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005; 15: 467-76. (Pubitemid 41253466)
41. Zhu C, Zhao J, Bibikova M, Leverson JD, Bossy-Wetzel E, Fan JB, Abraham RT, Jiang W,. Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell 2005; 16: 3187-99. (Pubitemid 40962591)
42. Gupta ML, Jr, Carvalho P, Roof DM, Pellman D,. Plus end-specific depolymerase activity of Kip3, a kinesin-8 protein, explains its role in positioning the yeast mitotic spindle. Nat Cell Biol 2006; 8: 913-23. (Pubitemid 44314722)
43. Hall A,. The cytoskeleton and cancer. Cancer Metastasis Rev 2009; 28: 5-14.
44. Wittmann T, Waterman-Storer CM,. Cell motility: can Rho GTPases and microtubules point the way? J Cell Sci 2001; 114: 3795-803. (Pubitemid 33094694)
45. Salmon WC, Adams MC, Waterman-Storer CM,. Dual-wavelength fluorescent speckle microscopy reveals coupling of microtubule and actin movements in migrating cells. J Cell Biol 2002; 158: 31-7.
46. Yagi N, Manabe I, Tottori T, Ishihara A, Ogata F, Kim JH, Nishimura S, Fujiu K, Oishi Y, Itaka K, Kato Y, Yamauchi M, et al. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res 2009; 69: 6531-8.
47. Akita H, Kogure K, Moriguchi R, Nakamura Y, Higashi T, Nakamura T, Serada S, Fujimoto M, Naka T, Futaki S, Harashima H,. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. J Control Release 2010; 143: 311-7.
48. Catarinella M, Gruner T, Strittmatter T, Marx A, Mayer TU,. BTB-1: a small molecule inhibitor of the mitotic motor protein Kif18A. Angew Chem Int Ed Engl 2009; 48: 9072-6.
49. Jordan MA, Wilson L,. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4: 253-65. (Pubitemid 38525281)
50. Chen SM, Meng LH, Ding J,. New microtubule-inhibiting anticancer agents. Expert Opin Investig Drugs 2009; 19: 329-43.